CompletedPHASE2, PHASE3NCT02071459

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Toulouse
Principal Investigator
Anne PAVY-LE-TRAON, PHD
University Hospital, Toulouse
Intervention
L-Threo DOPS(drug)
Enrollment
107 enrolled
Eligibility
30-80 years · All sexes
Timeline
20142019

Study locations (13)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02071459 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

See all trials for Multiple system atrophy

← Back to all trials